ER stress can lead to increased sensitivity of cancer cells to TRAIL treatment due to upregulation of DR5.24, 25 Conversely, Lu et al. noted that treatment with a high dose (>1 μM) of BFA mostly led to intracellular clustering of DR5 and therefore did not sensitize cells to TRAIL treatment.15 The gene discussed is TNFRSF10B; the disease is cancer.